Sale!

Sarcoma Gene Panel

Original price was: $3,750.Current price is: $2,812.

-25%

The Sarcoma Gene Panel is a comprehensive genetic test that analyzes tumor tissue using Next-Generation Sequencing (NGS) technology to identify specific genetic mutations associated with various sarcoma types. This advanced diagnostic tool helps oncologists understand the molecular profile of sarcoma tumors, enabling personalized treatment strategies and targeted therapies. The test examines multiple genes simultaneously, providing crucial information about tumor behavior, potential treatment responses, and disease progression. Patients benefit from precise diagnosis, optimized treatment selection, and improved management of their condition. With results available in 4-6 weeks, this panel offers valuable insights for both newly diagnosed patients and those with recurrent disease. The test requires a tumor tissue sample and costs $2812 USD, providing exceptional value for comprehensive genetic analysis.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Sarcoma Gene Panel: Comprehensive Genetic Analysis for Sarcoma Tumors

Understanding Sarcoma Gene Panel Testing

The Sarcoma Gene Panel represents a cutting-edge approach to cancer diagnostics, specifically designed to analyze the complex genetic landscape of sarcoma tumors. Sarcomas are rare cancers that develop in connective tissues such as bones, muscles, fat, nerves, and blood vessels. This comprehensive genetic test utilizes Next-Generation Sequencing (NGS) technology to examine multiple genes simultaneously, providing oncologists with detailed molecular information crucial for personalized treatment planning.

Traditional diagnostic methods often provide limited information about the genetic drivers of sarcoma development and progression. The Sarcoma Gene Panel overcomes these limitations by offering a comprehensive view of the tumor’s genetic makeup, enabling healthcare providers to make more informed decisions about treatment strategies and patient management.

What the Sarcoma Gene Panel Detects

This advanced genetic panel specifically targets and analyzes:

  • Key driver mutations in sarcoma-associated genes
  • Genetic alterations that influence treatment response
  • Biomarkers for targeted therapy selection
  • Prognostic indicators for disease progression
  • Resistance mutations that may affect treatment outcomes
  • Hereditary predisposition factors in certain sarcoma types

The test examines paraffin-embedded tissue blocks from tumor samples, providing a comprehensive genetic profile that helps identify the most effective treatment approaches for individual patients.

Who Should Consider Sarcoma Gene Panel Testing

This test is particularly beneficial for individuals experiencing:

  • Newly diagnosed sarcoma patients seeking comprehensive genetic profiling
  • Patients with recurrent or metastatic sarcoma requiring updated genetic analysis
  • Individuals with treatment-resistant sarcoma needing alternative therapeutic options
  • Patients with rare or unusual sarcoma subtypes requiring precise classification
  • Those considering participation in clinical trials for sarcoma treatments
  • Individuals with family history of sarcoma or related genetic conditions

Clinical Indications Include:

  • Unexplained soft tissue or bone masses
  • Rapidly growing tumors requiring urgent genetic characterization
  • Cases where standard treatments have shown limited effectiveness
  • Patients seeking personalized treatment approaches
  • Those requiring confirmation of sarcoma subtype diagnosis

Benefits of Sarcoma Gene Panel Testing

Undergoing comprehensive genetic analysis through the Sarcoma Gene Panel offers numerous advantages:

Personalized Treatment Planning

The detailed genetic information obtained helps oncologists develop tailored treatment strategies based on the specific molecular characteristics of each patient’s tumor. This approach increases the likelihood of treatment success while minimizing unnecessary side effects from ineffective therapies.

Improved Diagnostic Accuracy

By identifying specific genetic markers, the test provides precise classification of sarcoma subtypes, which is crucial for determining the most appropriate treatment protocols and predicting disease behavior.

Access to Targeted Therapies

The genetic profile generated may reveal eligibility for targeted therapies and clinical trials that specifically address the identified molecular alterations, potentially offering more effective treatment options.

Enhanced Prognostic Information

Understanding the genetic drivers of the tumor provides valuable insights into disease progression patterns and potential treatment responses, helping patients and physicians make informed decisions about long-term care.

Understanding Your Test Results

Your Sarcoma Gene Panel results will provide comprehensive information about the genetic landscape of your tumor. The report typically includes:

Genetic Alterations Identified

The test results will detail specific genetic mutations, amplifications, deletions, or rearrangements detected in your tumor sample. Each finding is carefully analyzed for clinical significance and potential therapeutic implications.

Clinical Interpretation

Our expert genetic counselors and oncologists provide clear explanations of how each genetic finding relates to your specific sarcoma type, including potential treatment implications and prognostic significance.

Therapeutic Recommendations

Based on the genetic profile, the report may suggest specific targeted therapies, clinical trial opportunities, or conventional treatment approaches that align with your tumor’s molecular characteristics.

Follow-up Guidance

Your healthcare provider will discuss the results with you in detail, explaining how this information impacts your treatment plan and what steps to take next in your cancer journey.

Test Pricing and Availability

Test Component Price (USD)
Sarcoma Gene Panel – Discount Price $2812
Sarcoma Gene Panel – Regular Price $3750

Turnaround Time: 4-6 weeks
Sample Type: Tumor tissue (Paraffin embedded tissue blocks)
Testing Method: Next-Generation Sequencing (NGS)

Pre-Test Instructions and Requirements

The Sarcoma Gene Panel requires a doctor’s prescription for testing. Please note that prescriptions are not applicable for surgery and pregnancy cases or individuals planning to travel abroad. Our team will guide you through the sample collection process and ensure proper handling of your tumor tissue sample.

Nationwide Testing Availability

We have branches across the United States, serving patients in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our extensive network ensures convenient access to advanced genetic testing regardless of your location.

Take Control of Your Sarcoma Treatment Today

Don’t leave your treatment decisions to chance. The Sarcoma Gene Panel provides the comprehensive genetic information needed to make informed decisions about your cancer care. With results available in 4-6 weeks and our team of genetic specialists ready to support you, now is the time to take the next step in your treatment journey.

Call us today at +1(267) 388-9828 to schedule your Sarcoma Gene Panel test or to speak with one of our genetic counseling specialists. Our team is available to answer your questions and help you understand how this advanced testing can benefit your specific situation.

Take advantage of our special discounted price of $2812 and gain access to the most comprehensive genetic analysis available for sarcoma patients. Your path to personalized cancer treatment begins with understanding your tumor’s genetic profile.